Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S De Groot

Showing results (51-60 of 177) with videos related to

Pageof 18
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approachKarina Winterling, William D Martin, Anne S De Groot, et al.
Vaccine|June 30, 2009
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopesLeonard Moise, Julie A McMurry, Soren Buus, et al.
Vaccine|February 13, 2007
Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccineJulie A McMurry, Stephen H Gregory, Leonard Moise, et al.
The Open AIDS Journal|January 5, 2013
HIV-1 Vaccine Trials: Evolving Concepts and DesignsMissa P Sanou, Anne S De Groot, Michael Murphey-Corb, et al.
Human Vaccines & Immunotherapeutics|August 14, 2020
Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challengeHyesun Jang, Lauren M Meyers, Christine Boyle, et al.
Frontiers in Public Health|June 21, 2021
Recruitment, Training, and Roles of the Bilingual, Bicultural <i>Navegantes</i>: Developing a Specialized Workforce of Community Health Workers to Serve a Low-Income, Spanish-Speaking Population in Rhode IslandMeghan McCarthy, Katherine Barry, Cindy Estrada, et al.
Advanced Drug Delivery Reviews|July 22, 2009
T cell epitope: friend or foe? Immunogenicity of biologics in contextConstanze A Weber, Preema J Mehta, Matt Ardito, et al.
Human Vaccines & Immunotherapeutics|June 29, 2013
Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine designAnne S De Groot, Matthew Ardito, Frances Terry, et al.
Drug Discovery Today|July 19, 2023
Immunogenicity risk assessment of synthetic peptide drugs and their impuritiesAnne S De Groot, Brian J Roberts, Aimee Mattei, et al.
Frontiers in Immunology|May 2, 2025
Regulatory T cell epitope content in human antibodies decreases during maturationAndres H Gutierrez, Frances E Terry, Amy S Rosenberg, et al.
Pageof 18

Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approachKarina Winterling, William D Martin, Anne S De Groot, et al.
Vaccine|June 30, 2009
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopesLeonard Moise, Julie A McMurry, Soren Buus, et al.
Vaccine|February 13, 2007
Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccineJulie A McMurry, Stephen H Gregory, Leonard Moise, et al.
The Open AIDS Journal|January 5, 2013
HIV-1 Vaccine Trials: Evolving Concepts and DesignsMissa P Sanou, Anne S De Groot, Michael Murphey-Corb, et al.
Human Vaccines & Immunotherapeutics|August 14, 2020
Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challengeHyesun Jang, Lauren M Meyers, Christine Boyle, et al.
Frontiers in Public Health|June 21, 2021
Recruitment, Training, and Roles of the Bilingual, Bicultural <i>Navegantes</i>: Developing a Specialized Workforce of Community Health Workers to Serve a Low-Income, Spanish-Speaking Population in Rhode IslandMeghan McCarthy, Katherine Barry, Cindy Estrada, et al.
Advanced Drug Delivery Reviews|July 22, 2009
T cell epitope: friend or foe? Immunogenicity of biologics in contextConstanze A Weber, Preema J Mehta, Matt Ardito, et al.
Human Vaccines & Immunotherapeutics|June 29, 2013
Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine designAnne S De Groot, Matthew Ardito, Frances Terry, et al.
Drug Discovery Today|July 19, 2023
Immunogenicity risk assessment of synthetic peptide drugs and their impuritiesAnne S De Groot, Brian J Roberts, Aimee Mattei, et al.
Frontiers in Immunology|May 2, 2025
Regulatory T cell epitope content in human antibodies decreases during maturationAndres H Gutierrez, Frances E Terry, Amy S Rosenberg, et al.
Pageof 18